Working Through It.
Remaining an Essential Business During the COVID-19 Pandemic
Nobody could have predicted the massive affects, and changes the world has seen due to the SARS-CoV-2 pandemic. The world continues to adapt, adjust, and modify its way of life during this uncertain time. During these changes, and as it continually evolves, so too has Lovelace Biomedical’s operations.
As always, Lovelace Biomedical is here, helping pharmaceutical companies and all of our clients, research their investigational drugs out of the preclinical stage, and onto clinical trials. We ARE designated as an essential business, and therefore our doors will not be temporarily shut due to Coronavirus.
We are closely working with collaborators to help identify treatments and vaccines to fight this infectious disease. We have also been awarded work due to our past history in working with the SARS virus in 2004. Our lab, built on a bio-secure facility, closed and far from the public, is operating and we are currently using our multi-disciplinary expertise to aid in the fight the world is facing.
As previously mentioned in a past communication, we have made our facilities safe by following the guidelines set forth by the Center for Disease Control, and the World Health Organization. We have made sure our non-essential employees can work from home, and we are practicing social distancing. Along with other organizations, our own adjustments and solutions make it possible for us to continue operating and remain a necessary part of helping to improve human health.
If you need our assistance in any preclinical research, including the fight against SARS-CoV-2, please be assured we are here to provide our vast knowledge and we will see your studies through. Please contact us!
All the best during these unfamiliar challenges as we navigate them together.
– Lovelace Biomedical